Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

IntroductionLong-chain omega-3 polyunsaturated fatty acids (OM3 PUFA) are commonly used for cardiovascular disease prevention. High-dose eicosapentaenoic acid (EPA) is reported to reduce major adverse cardiovascular events (MACE); however, a combined EPA and docosahexaenoic acid (DHA) supplementatio...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Viet T. Le, Stacey Knight, Jeramie D. Watrous, Mahan Najhawan, Khoi Dao, Raymond O. McCubrey, Tami L. Bair, Benjamin D. Horne, Heidi T. May, Joseph B. Muhlestein, John R. Nelson, John F. Carlquist, Kirk U. Knowlton, Mohit Jain, Jeffrey L. Anderson
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2023-08-01
Reeks:	Frontiers in Cardiovascular Medicine
Onderwerpen:	EPA DHA major adverse cardiovascular events omega-3 outcomes
Online toegang:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1229130/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!